2009 - PhD Biochemistry, University of Warwick
2005 - MSc Biomedical Sciences, University of Glasgow
Dr Graham obtained his degree in Biomedical Sciences at the University of Glasgow in 2005 before pursuing a PhD at the University of Warwick and the Institute for Animal Health, where he studied prion diseases. His PhD project was an investigation into strain-specific co-factors that stimulate prion protein conversion. As a post-doctoral research scientist at The Roslin Institute in Edinburgh, Dr Graham developed an analytical in vitro assay that would analyze the risk factor of newly discovered animal prion diseases to infect humans. He then moved to the German Center for Neurodegenerative Diseases in Bonn, Germany, where he used his prion strain knowledge to work on the novel concept of alpha-synuclein strains in Parkinson's disease and other synucleinopathies.
As an academic scientist, Dr Graham has been involved in the writing of eight peer-reviewed publications and was an official reviewer for the journal PLOS ONE.
Dr Graham began pursuing a career in medical communications in 2014. He writes and edits for a number of dedicated clients in the education, pharmaceutical, and not-for-profit sectors. He was appointed to the Executive Committee of the Australasian Medical Writers Association (AMWA) in August 2016. He joined Edanz Group as a medical writer in 2016.